Add office photos
Engaged Employer
Dr. Reddy's
4.0
based on 7.4k Reviews
Video summary
Proud winner of ABECA 2025 - AmbitionBox Employee Choice Awards
Company Overview
Associated Companies
Company Locations
Working at Dr. Reddy's
Company Summary
We are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’
Overall Rating
4.0/5
based on 7.4k reviews
3% above
industry average
Highly rated for
Skill development, Company culture, Salary
Critically rated for
Promotions
Work Policy
Work from office
73% employees reported
Monday to Friday
40% employees reported
Flexible timing
67% employees reported
No travel
38% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
491 employees reported
Health insurance
411 employees reported
Cafeteria
279 employees reported
Child care facility
262 employees reported
View all benefits
About Dr. Reddy's
Founded in1984 (41 yrs old)
India Employee Count10k-50k
Global Employee Count10k-50k
India HeadquartersHyderabad/Secunderabad, Telangana, India
Office Locations
Websitedrreddys.com
Primary Industry
Other Industries
View in video summary
We started in 1984 with a modest investment and a bold vision. Today, with research and development centres, manufacturing facilities and commercial presence across the globe, we serve over half a billion patients worldwide. We aspire to triple our reach and touch over 1.5 billion patients by 2030.
We are committed to providing access to affordable and innovative medicines, driven by our purpose of ‘Good Health Can’t Wait’.
Our products and services are spread across our core businesses of Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars and over-the-counter pharmaceutical products around the world. We work towards meeting unmet patients needs in the areas of gastro-enterology, cardiovascular, diabetology, oncology, pain management and dermatology. We are investing in businesses of the future including drug discovery, clinically-differentiated assets and digital healthcare.
Report error
ABECA - AmbitionBox Employee Choice Awards
Best of the best, rated by employees
Dr. Reddy's won India’s Largest Employee Choice Awards in Large Companies Category.
Top Rated Pharma Company
Share
Dr. Reddy's Ratings
based on 7.4k reviews
Overall Rating
4.0/5
How AmbitionBox ratings work?
5
3.8k
4
2k
3
757
2
306
1
451
Category Ratings
3.9
Skill development
3.8
Company culture
3.8
Salary
3.8
Work-life balance
3.7
Work satisfaction
3.5
Job security
3.3
Promotions
Dr. Reddy's is rated 4.0 out of 5 stars on AmbitionBox, based on 7.4k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Dr. Reddy's
based on 7k reviews
3.9
Rated by 846 Women
Rated 3.8 for Company culture and 3.7 for Work-life balance
4.0
Rated by 6.2k Men
Rated 4.0 for Skill development and 3.9 for Company culture
Work Policy at Dr. Reddy's
based on 866 reviews in last 6 months
Work from office
73%
Hybrid
23%
Permanent work from home
4%
Dr. Reddy's Reviews
Top mentions in Dr. Reddy's Reviews
+ 5 more
Compare Dr. Reddy's with Similar Companies
 |  Change Company |  Change Company |  Change Company | |
|---|---|---|---|---|
Overall Rating | 4.0/5 based on 7.4k reviews | 4.0/5 based on 6.5k reviews | 4.1/5 based on 6.6k reviews | 4.1/5 based on 7.5k reviews |
Highly Rated for | Skill development Work-life balance Salary | Salary Skill development Job security | Skill development Company culture Work-life balance | Skill development Salary Work-life balance |
Critically Rated for | Promotions |  No critically rated category | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 73% employees reported | Work from office 85% employees reported | Work from office 82% employees reported | Work from office 73% employees reported |
Rating by Women Employees | 3.9 Good rated by 846 women | 3.9 Good rated by 412 women | 4.0 Good rated by 409 women | 4.0 Good rated by 763 women |
Rating by Men Employees | 4.0 Good rated by 6.2k men | 4.0 Good rated by 5.5k men | 4.1 Good rated by 5.9k men | 4.1 Good rated by 6.4k men |
Job security | 3.5 Good | 3.8 Good | 3.7 Good | 3.7 Good |
View more
Dr. Reddy's Salaries
Dr. Reddy's salaries have received with an average score of 3.8 out of 5 by 7.4k employees.
Team Member
(4.1k salaries)
Unlock
₹3.4 L/yr - ₹10.4 L/yr
Analytical Scientist
(880 salaries)
Unlock
₹5.8 L/yr - ₹12.8 L/yr
Team Lead
(516 salaries)
Unlock
₹11.2 L/yr - ₹18.9 L/yr
Area Sales Manager
(449 salaries)
Unlock
₹6.2 L/yr - ₹13 L/yr
Senior Team Member
(413 salaries)
Unlock
₹5.4 L/yr - ₹12.2 L/yr
Territory Manager
(317 salaries)
Unlock
₹3.5 L/yr - ₹7.4 L/yr
Scientist
(317 salaries)
Unlock
₹5.1 L/yr - ₹13.4 L/yr
Production Specialist
(295 salaries)
Unlock
₹3.5 L/yr - ₹7.8 L/yr
Research Associate
(283 salaries)
Unlock
₹4.5 L/yr - ₹10 L/yr
Formulation Scientist
(271 salaries)
Unlock
₹5.7 L/yr - ₹13 L/yr
Dr. Reddy's Interview Questions
Dr. Reddy's Jobs
Popular Designations Dr. Reddy's Hires for
Popular Skills Dr. Reddy's Hires for
Current Openings
Dr. Reddy's News
View all
Stock Market Live: GIFT Nifty Implies Negative Open; Vedanta, Hindalco, Cipla, Lupin, Dr. Reddy's In Focus
- Indian markets are expected to open lower due to weak global cues with the Nifty 50 likely to have support at 25,400 and resistance at 25,600.
- Global markets, including Asia and the US, experienced declines following announcements by US President Donald Trump of tariffs on copper and pharmaceutical imports, leading to a negative sentiment in the markets.
- The GIFT Nifty was trading down, indicating a negative open. Investors might focus on companies like JSW Steel, Tata Steel, Seamec, Dixon Technology, and Rail Vikas Nigam for news impact.
- The Nifty 50 and BSE Sensex closed higher on the previous day, influenced by Kotak Mahindra Bank and HDFC Bank performance, amidst trade deal uncertainties between the US and India.
Bloomberg Quint | 9 Jul, 2025
Janesh Kumar is the new CHRO, Genus Power Infrastructures
- Janesh Kumar has been appointed as the new Chief Human Resources Officer (CHRO) at Genus Power Infrastructures, after serving RP Sanjiv Goenka Group for over five years.
- Janesh Kumar, an alumnus of Symbiosis Institute of Management Studies, has a background in mechanical engineering and has held various HR roles at companies like Bajaj Auto Ancillary, JSW Steel, Dr. Reddy's Laboratories, Abbott, Airtel, and RP Sanjiv Goenka Group.
- Genus Power Infrastructures, a manufacturing company specializing in smart metering solutions, expects Janesh Kumar's energy, agility, and focus on innovation to create a vibrant workplace environment.
- Janesh Kumar expressed excitement about his new role, mentioning his passion for sparking innovation in sustainable technology and contributing to a purpose he deeply believes in, receiving good wishes for his journey from HRKatha.
HRKatha | 7 Jul, 2025
Stock Market Highlights: Nifty, Sensex Log Nearly 1% Weekly Decline; Realty Top Dragger
- The NSE Nifty 50 and BSE Sensex closed higher on Friday but logged nearly a 1% weekly decline overall.
- Notably, the Nifty Realty sector was the worst-performing sector with a drop of over 2% for the week.
- Nifty Pharma and PSU Bank indices posted gains, while Nifty Midcap 150 and Smallcap 250 indices recorded consecutive gains.
- Top gainers in the Nifty included Bajaj Finance Ltd., Infosys Ltd., and Dr. Reddy's Laboratories Ltd., while Trent Ltd., Tata Steel Ltd., Eicher Motors Ltd., and Tech Mahindra Ltd. were among the biggest losers.
Bloomberg Quint | 4 Jul, 2025
Sensex crosses 84,000 mark; Jio, IndusInd lead gainers, paint stocks Asian Paints & Akzo Nobel soar
- Sensex crossed the 84,000 mark, climbing 244.92 points to 84,000.79.
- Gainers in Nifty 50 included Jio Financial, IndusInd, and Asian Paints, while Bajaj Finance and Dr. Reddy’s Laboratories were among the major laggards.
- Asian shares rose following US stocks nearing record highs.
- Stocks like HDB's $1.5 billion IPO selling out and companies like Wakefit filing for a significant IPO were highlighted among market movements.
HinduBusinessLine | 27 Jun, 2025
Success of Telangana’s Young India Skill University will be dependent on its offerings
- Telangana's Young India Skill University aims to bridge the gap between evolving tech industry demands and traditional education systems.
- The university collaborates with leading companies like AIG hospitals, Lenskart, Dr. Reddys, Flipkart, and TCSion to impart relevant skills.
- Opinions about the success of the university vary among students from different educational backgrounds.
- While students from top institutes like BITS Pilani and IIT Hyderabad feel adequately prepared for the job market, others are more hopeful about the courses at the new university.
- The university strives to stay updated by frequently revising its syllabi based on industry trends.
- Challenges in the job market include a shift towards AI, affecting entry-level coding jobs for fresh graduates.
- Hyderabad career coaches support the government's focus on cross-functional and communication skills.
- Industry experts emphasize the importance of experiential learning for students.
- The success of Telangana’s Young India Skill University hinges on its ability to adapt to industry demands and provide relevant skills to students.
HinduBusinessLine | 17 Jun, 2025
Sensex, Nifty 50 rally sharply on gains in IT, realty, metal, oil & gas
- Sensex and Nifty 50 closed significantly higher with Sensex up by 0.84% at 81,796.15 and Nifty 50 up by 0.92% at 24,946.50.
- Geopolitical tensions between Israel and Iran did not deter market gains, supported by large-cap stocks and focus on long-term fundamentals.
- WPI inflation lowered to 0.4% in May, with oil price surge causing inflation concerns tempered by recent CPI data slowdown.
- Tata Motors stock dropped nearly 4% due to FY26 margin forecast cuts by JLR.
- Midcap and smallcap indexes rose by around 0.93% and 0.95% respectively, while sectoral indices like IT, tourism, realty, oil & gas, and metal experienced over 1% gains.
- Oil and gas sector's positive trend was driven by reports suggesting potential EV policy revisions benefiting gas distribution companies.
- Defence and crude-related stocks amidst Israel-Iran conflict and monsoon-linked sectors like fertilisers expected to be in focus.
- Stock gainers in Nifty 50 included Bharat Electronics, HDFC Life, ONGC, while losers were Tata Motors, Sun Pharma, and Dr Reddy’s Laboratories.
- Among midcaps, IGL and Supreme Industries surged, while Page Industries, Mazagon Dock, and MRF declined.
- In the smallcap index, Newgen Software, MCX, Atul, and IIFL saw significant gains.
- Sterlite Technologies, Cosmo First, Axiscades, and Unimech were among the stocks hitting upper circuits, while some stocks reached 52-week highs and lows.
- Market resilience highlighted amid geopolitical tensions by experts recommending cautious trading and focusing on less volatile stocks.
- Rupee traded positively, Asian markets settled high, while Wall Street closed lower on Friday, and Indian indexes also dipped with FIIs selling equities.
- Macro focus on Bank of Japan’s interest rate decision and upcoming US May retail sales data.
- Crude oil prices remained range-bound with expected rupee volatility due to the US Fed interest rate decision and India’s inflation data.
- Asian markets concluded positively while Sensex and Nifty closed lower the previous day with FIIs selling off equities worth ₹1,263.52 crore.
HinduBusinessLine | 16 Jun, 2025
Nifty 50 Top Gainers, Losers On June 16: HDFC Life, UltraTech To Tata Motors
- The Nifty 50 index ended 0.92% higher at 24,946.50, while the BSE Sensex closed 0.84% up at 81,796 on June 16.
- BEL, SBI Life, UltraTech Cement, HDFC Life, and ONGC were the top gainers, with Bharat Electronics showing the most increase at 2.45%.
- Tata Motors, Dr. Reddy's Laboratories, Adani Ports, and Sun Pharma were the top losers for the day.
- Tata Motors witnessed the biggest decline, closing 3.57% lower, while the benchmark indices closed higher despite the two-session losing streak.
- Nifty gained 1.01% during the day to trade at 24,967.10, and Sensex gained 0.92% to close at 81,865.82.
Bloomberg Quint | 16 Jun, 2025
Pharma, Chemicals Drive India’s $5.9 Billion Exports To Canada In 2024
- India's bilateral trade in goods with Canada reached $9.8 billion in 2024, with India exporting $5.9 billion and importing $3.9 billion.
- Bilateral services trade between India and Canada stood at $13.7 billion in 2024, with India exporting services worth $2.58 billion.
- Over 600 Canadian companies operate in India, while Indian companies are active in Canada in various sectors.
- India's pharmaceutical exports to Canada increased by 20.4% in 2024 to $511.79 million.
- Key Indian drugmakers like Dr. Reddy's, Sun Pharma, and Cipla have strengthened their presence in Canada.
- India exported $225.91 million worth of organic chemicals to Canada in 2024.
- Canada remains a key supplier of raw materials like potash to India, with imports seeing a decline from April to December 2024.
- Indian firms like Coromandel International and Chambal Fertilizers have agreements with Canadian exporters for potash supply.
Bloomberg Quint | 16 Jun, 2025
Nifty 50 Top Gainers, Losers On June 12: Asian Paints, Tata Motors To Trent
- On June 12, the NSE Nifty 50 closed 1.01% down at 24,888.2, while the BSE Sensex closed 1% lower at 81,691.98.
- Winners on Thursday included Apollo Hospitals, Dr. Reddy's, Bajaj Finserv, Asian Paints, and Tech Mahindra.
- Losers on the same day were Tata Motors, Shriram Finance, Trent, Titan Co., and Coal India.
- Apollo Hospitals was the biggest gainer, closing 1% higher at Rs 6,996.50, followed by Dr. Reddy's and Bajaj Finserv.
- Tata Motors was the biggest laggard closing 2.86% lower at Rs 715.35, followed by Shriram Finance and Trent.
- The Nifty and Sensex slumped due to the drag from Larsen & Toubro Ltd. and Infosys Ltd., with Nifty ending at 24,888.2 and Sensex closing at 81,691.98.
- Both Nifty and Sensex opened on a muted note, trading in a narrow range, before declining later in the session.
- During the last leg of the trade, Nifty dropped 1.25% to reach 24,825.9, and Sensex decreased by 1.20% to 81,523.16.
Bloomberg Quint | 12 Jun, 2025
Stock Market Highlights: Nifty, Sensex End Little Changed After Tuesday's Decline
- The NSE Nifty 50 closed 0.15% higher at 25,141, while the BSE Sensex ended 0.15% up at 82,515.
- During the day, the Nifty rose 0.47% to trade at 25,222.49 and the Sensex advanced 0.48% to 82,783.51.
- The markets saw an inverted V-shaped movement, with a surge in IT stocks but a subsequent decline in Midcap and Smallcap segments.
- Top gainers included Grasim Industries Ltd., Dr. Reddy's Laboratories Ltd., and Tech Mahindra Ltd.
- Top laggards were Trent Ltd., Maruti Suzuki India Ltd., and Asian Paints Ltd.
- Infosys Ltd. and Reliance Industries Ltd. contributed to gains, while HDFC Bank Ltd., Power Grid Corp., and Shriram Finance Ltd. dragged the index.
- On NSE, nine out of 15 sectors ended in the red, with Nifty Oil & Gas, IT, and Pharma among the top losers.
- The BSE MidCap closed down 0.12%, while the BSE SmallCap gained 0.06%.
- Market breadth favored buyers with 2,228 stocks advancing, 1,824 declining, and 124 remaining unchanged on the BSE.
Bloomberg Quint | 11 Jun, 2025
Powered by
Dr. Reddy's Subsidiaries
Aurigene Oncology Limited
4.2
• 273 reviews
Aurigene Pharmaceutical Services
4.2
• 260 reviews
SVAAS Wellness
3.7
• 16 reviews
Report error
Dr. Reddy's Offices
Compare Dr. Reddy's with
Sun Pharmaceutical Industries
4.0
Aurobindo Pharma
4.0
Intas Pharmaceuticals
4.1
Hetero
3.9
Macleods Pharmaceuticals
3.6
Viatris
4.2
Alembic Pharmaceuticals
4.0
Abbott
4.1
Glenmark Pharmaceuticals
3.8
Ipca Laboratories
3.9
Alkem Laboratories
3.9
Mankind Pharma
3.9
Torrent Pharmaceuticals
3.9
MSN Laboratories
3.6
Ajanta Pharma
4.0
Akums Drugs & Pharmaceuticals Limited
4.3
GlaxoSmithKline Pharmaceuticals
4.1
Pfizer
3.9
DIVI'S Laboratories
3.6
Wockhardt
3.8
Contribute & help others!
You can choose to be anonymous
Companies Similar to Dr. Reddy's
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.0
• 6.5k reviews
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 6.4k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 5.2k reviews
Intas Pharmaceuticals
Biotech & Life sciences, Pharma
4.1
• 3.8k reviews
Hetero
Healthcare / Pharma, Clinical Research, Healthcare, Pharma
3.9
• 3.7k reviews
Macleods Pharmaceuticals
Biotech & Life sciences, Pharma
3.6
• 3.7k reviews
Viatris
Manufacturing, Pharma
4.2
• 3.4k reviews
Alembic Pharmaceuticals
Real Estate, Engineering & Construction, Biotechnology, Pharma
4.0
• 3.4k reviews
Abbott
Healthcare / Pharma, Media & Entertainment / Publishing, Pharma
4.1
• 3.3k reviews
Glenmark Pharmaceuticals
Pharma
3.8
• 3.2k reviews
Dr. Reddy's FAQs
When was Dr. Reddy's founded?
Dr. Reddy's was founded in 1984. The company has been operating for 41 years primarily in the Pharma sector.
Where is the Dr. Reddy's headquarters located?
Dr. Reddy's is headquartered in Hyderabad / Secunderabad, Telangana. It operates in 6 cities such as Hyderabad / Secunderabad, Visakhapatnam, Baddi, Srikakulam, Bangalore / Bengaluru. To explore all the office locations, visit Dr. Reddy's locations.
How many employees does Dr. Reddy's have in India?
Dr. Reddy's currently has more than 21,000+ employees in India. Research & Development department appears to have the highest employee count in Dr. Reddy's based on the number of reviews submitted on AmbitionBox.
Does Dr. Reddy's have good work-life balance?
Dr. Reddy's has a Work-Life Balance Rating of 3.8 out of 5 based on 7,300+ employee reviews on AmbitionBox. 79% employees rated Dr. Reddy's 4 or above, while 21% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Dr. Reddy's work-life balance reviews for more details.
Is Dr. Reddy's good for career growth?
Career growth at Dr. Reddy's is rated as moderate, with a promotions and appraisal rating of 3.3. 21% employees rated Dr. Reddy's 3 or below, while 79% employees rated it 4 or above on promotions / appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Dr. Reddy's promotions / appraisals reviews for more detailed insights.
What are the pros and cons of working in Dr. Reddy's?
Working at Dr. Reddy's comes with several advantages and disadvantages. It is highly rated for skill development, company culture and salary & benefits. However, it is poorly rated for promotions / appraisal, job security and work satisfaction, based on 7,300+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Trusted by over 1.5 Crore job seekers to find their right fit company
80 Lakh+
Reviews
10L+
Interviews
4 Crore+
Salaries
1.5 Cr+
Users
Contribute to help millions
AmbitionBox Awards
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2025 Info Edge (India) Ltd.
Follow Us
